We are live on ! Find out more
DM

Deerfield Management Portfolio holdings

AUM $8.48B
1-Year Est. Return 99.04%
This Fund
S&P 500
This Quarter Est. Return
+18.68%
1 Year Est. Return
+99.04%
3 Year Est. Return
+273.78%
5 Year Est. Return
+280.99%
10 Year Est. Return
+2,168.14%
AUM
$6.69B
AUM Growth
+$682M
Cap. Flow
-$395M
Cap. Flow %
-5.9%
Top 10 Hldgs %
54.02%
Holding
678
New
246
Increased
85
Reduced
72
Closed
235

Top Buys

Rank Stock Value
1
NBIX icon
Neurocrine Biosciences
NBIX
+$85.8M
2
INDV icon
Indivior Pharmaceuticals
INDV
+$59.6M
3
BCAX
Bicara Therapeutics
BCAX
+$45.8M
4
MRUS
Merus
MRUS
+$34.4M
5
VTRS icon
Viatris
VTRS
+$30M

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$102M
2
SGRY icon
Surgery Partners
SGRY
+$86.4M
3
CPRX
Catalyst Pharmaceutical
CPRX
+$53.7M
4
IART icon
Integra LifeSciences
IART
+$42.8M
5
BNTX icon
BioNTech
BNTX
+$38.6M

Sector Composition

Rank Sector Weight
1 Healthcare 87.45%
2 Industrials 0.73%
3 Technology 0.55%
4 Financials 0.45%
5 Consumer Discretionary 0.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CHD icon
476
Church & Dwight Co
CHD
$23.4B
– –
-4,331
Closed -$449K
CHWY icon
477
Chewy
CHWY
$9.25B
– –
-17,835
Closed -$486K
CLSK icon
478
CleanSpark
CLSK
$3.53B
– –
-40,519
Closed -$646K
CMC icon
479
Commercial Metals
CMC
$7.6B
– –
-13,115
Closed -$721K
CNO icon
480
CNO Financial Group
CNO
$5.14B
– –
-32,062
Closed -$889K
COIN icon
481
Coinbase
COIN
$38.6B
– –
-1,667
Closed -$370K
COOP
482
DELISTED
Mr. Cooper
COOP
– –
-3,164
Closed -$257K
CPRT icon
483
Copart
CPRT
$27B
– –
-4,762
Closed -$258K
CRBG icon
484
Corebridge Financial
CRBG
$14.1B
– –
-17,168
Closed -$500K
CSV icon
485
Carriage Services
CSV
$641M
– –
-53,584
Closed -$1.44M
CTRE icon
486
CareTrust REIT
CTRE
$9.91B
– –
-26,276
Closed -$660K
CTRN icon
487
Citi Trends
CTRN
$555M
– –
-9,807
Closed -$208K
CVGW
488
DELISTED
Calavo Growers
CVGW
– –
-70,514
Closed -$1.6M
CVX icon
489
Chevron
CVX
$392B
– –
-1,559
Closed -$244K
DBX icon
490
Dropbox
DBX
$7.6B
– –
-20,820
Closed -$468K
DCI icon
491
Donaldson
DCI
$10.9B
– –
-9,389
Closed -$672K
DHC
492
Diversified Healthcare Trust
DHC
$2.15B
– –
-88,223
Closed -$269K
DIS icon
493
Walt Disney
DIS
$167B
– –
-3,386
Closed -$336K
DLB icon
494
Dolby
DLB
$5.51B
– –
-4,587
Closed -$363K
DMRC icon
495
Digimarc Corp
DMRC
$147M
– –
-17,769
Closed -$551K
DOCS icon
496
Doximity
DOCS
$3.76B
– –
-19,315
Closed -$540K
DRI icon
497
Darden Restaurants
DRI
$23.3B
– –
-14,344
Closed -$2.17M
DXC icon
498
DXC Technology
DXC
$1.82B
– –
-13,613
Closed -$260K
EGP icon
499
EastGroup Properties
EGP
$11.2B
– –
-2,610
Closed -$444K
EPC icon
500
Edgewell Personal Care
EPC
$1.25B
– –
-30,788
Closed -$1.24M
18 19
20
21 22

Similar funds

FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
VA
Valmark Advisers Akron, Ohio $8.42B AUM 14.36% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $8.4B AUM 63.34% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return
AAF
Andra AP-fonden Goteborg, Sweden $8.39B AUM 21.19% 1-Year Est. Return

Deerfield Management's Q3 2024 Portfolio in Review

As of Q3 2024, Deerfield Management held 678 positions worth $6.69B, up 11% from $6.01B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Deerfield Management withdrew a net $395M in Q3 2024, closing 235 positions and reducing 72 holdings. Its most notable exit was Gilead Sciences, an estimated $102M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 87% of assets, up from 83% a quarter earlier, followed by Industrials and Technology.

Against the trend, Deerfield Management opened a new position in Indivior Pharmaceuticals worth $49.7M.

  • Deerfield Management's largest Q3 2024 buy was Indivior Pharmaceuticals: 5,092,642 shares worth $49.7M.
  • Deerfield Management added most to Neurocrine Biosciences in Q3 2024, an estimated $85.8M increase.
  • Deerfield Management's biggest Q3 2024 reduction was Surgery Partners, cutting an estimated $86.4M.
  • Deerfield Management fully exited Gilead Sciences in Q3 2024, selling an estimated $102M.
  • Deerfield Management's ten largest holdings make up 54% of its $6.69B portfolio in Q3 2024.
  • Deerfield Management opened 246 new positions and closed 235 in Q3 2024.
  • Deerfield Management's portfolio value rose 11% quarter-over-quarter to $6.69B.

Based on Deerfield Management's 13F filing for Q3 2024, filed 14 Nov 2024.